Totals
- Total revenue
- $395,212
- Total expenses
- $665,000
- Contributions and grants received
- $395,212
- Grants paid
- $0
- Program service revenue
- $0
- Investment income
- $0
- Other revenue
- $0
- Total assets, end of year
- $189,521
- Total liabilities, end of year
- $6,889
- Net assets or fund balances, end of year
- $182,632
- Program services expenses (Part IX)
- $541,800
- Management and general expenses
- $123,200
- Fundraising expenses
- $0
- Program service expenses (Part III)
- $541,800
Program services were 81.5% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Listed in Part VII
-
MAYA MITALIPOVA
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 0
-
SUSAN O'SULLIVAN
CO-CHAIR
- Total calculated
- $0
- Hours/week
- 0.5
-
SAMET AWUT
TREASURER
- Total calculated
- $0
- Hours/week
- 0.5
-
KAREN GUBERMAN
SECRETARY
- Total calculated
- $0
- Hours/week
- 0.5
-
CARL GERSHMAN
CO-CHAIR
- Total calculated
- $0
- Hours/week
- 0.5
-
MEHMET KANAT
EXECUTIVE DIRECTOR
- Total calculated
- $80,033
- From this org
- $80,033
- From related orgs
- $0
- Other
- $0
- Hours/week
- 40
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those.
Grants on this return
No itemized grants to organizations on this return.
Provenance
- Return type
- form_990
- Tax year
- 2025
- Filed
- 26 June 2026
- IRS schema version
- 2025v4.2
- Source object
- 202611779349301281
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.